Trials / Completed
CompletedNCT07164417
Two Types of PRF Membranes in Management of Dehiscence Defect in Posterior Mandible
Comparing Two Types of PRF Membranes in Management of Dehiscence Defect With Simultaneous Implant Placement in Posterior Mandible (Randomized Controlled Clinical Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Background: Placement of implants in an atrophic posterior ridge is a challenge for so many clinicians. The success of dental implants depends on the volume of alveolar bone available to provide stability. Bone grafting using xenograft with PRF and e-PRF as a membrane has shown promising results in both bone healing and defect reconstruction. Aim of the study: to evaluate the effect of Platelet-rich fibrin (PRF) and Extended Platelet-rich fibrin (e-PRF) as a membrane with xenograft to increase the width of ridge in posterior mandible with simultaneous implant placement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | e-PRF membrane will be used with xenograft simultaneously with implant placement. | Peripheral blood is collected in plain tubes and centrifuged (700-2000 g, 8 min) to separate plasma from red cells. The first 2-4 mL of platelet-poor plasma (PPP) is withdrawn and heated at 75 °C for 10 minutes to form albumin gel, then cooled for 1-2 minutes. Meanwhile, the remaining blood fractions (buffy coat, liquid PRF, red cells) are kept cooled to prevent premature clotting. |
| OTHER | PRF membrane will be used with xenograft simultaneously with implant placement | Peripheral blood is collected in 9-10 mL additive-free tubes and centrifuged horizontally at 700-2000 g for 8 minutes. |
Timeline
- Start date
- 2024-10-12
- Primary completion
- 2025-01-20
- Completion
- 2025-01-20
- First posted
- 2025-09-10
- Last updated
- 2025-09-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07164417. Inclusion in this directory is not an endorsement.